Stock listing
MIST Stock Price, News, Filings & Events — Milestone Pharmaceuticals Inc.
Selected listing: MIST · NASDAQ · USD · US
This page tracks Milestone Pharmaceuticals Inc.'s MIST:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MIST:NASDAQ. MIST:NASDAQ is the stock-level entry point for investors researching Milestone Pharmaceuticals Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Milestone Pharmaceuticals Inc. is a public company traded under the ticker MIST in the American market. The company has a market capitalization of approximately $144.4 million. Milestone focuses on developing innovative therapies for cardiovascular diseases.
- Ticker
- MIST:NASDAQ
- Asset type
- Stock
- Market cap
- $122.0M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Milestone Pharmaceuticals Inc. MIST:NASDAQ stock context
This page tracks Milestone Pharmaceuticals Inc.'s MIST:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MIST:NASDAQ. MIST:NASDAQ is the stock-level entry point for investors researching Milestone Pharmaceuticals Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Milestone Pharmaceuticals Inc. is a public company traded under the ticker MIST in the American market. The company has a market capitalization of approximately $144.4 million. Milestone focuses on developing innovative therapies for cardiovascular diseases.
Latest news from Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Announces NMPA Approval of Etripamil Nasal Spray for PSVT in China, Marking First Regulatory Approval of Etripa...
September 3, 2026
Milestone Pharmaceuticals to Present at Upcoming Investor Conferences
September 2, 2026
Milestone Pharmaceuticals Announces Data Presented at ESC Congress 2026 on the Impact of Paroxysmal Supraventricular Tachycardia (PSVT) o...
August 27, 2026
Milestone Pharmaceuticals Initiates Pivotal Phase 3 Trial of Etripamil Nasal Spray for Self-Administered Treatment of Atrial Fibrillation...
August 21, 2026
Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update
August 12, 2026
Milestone Pharmaceuticals Inc. earnings calls
Milestone Pharmaceuticals Inc. (MIST) Q2 2026 Earnings Call
August 12, 2026 · Replay with transcript and chapters
Milestone Pharmaceuticals Inc. (MIST) Q1 2026 Earnings Call
May 13, 2026 · Replay with transcript and chapters
Milestone Pharmaceuticals Inc. (MIST) Q4 2025 Earnings Call
March 20, 2026 · Replay with transcript and chapters
Milestone Pharmaceuticals Inc. (MIST) Q3 2023 Earnings Call
November 13, 2023 · Replay with transcript and chapters
Research Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc. investor report
Review AI stock analysis and investor report context for MIST:NASDAQ.
Milestone Pharmaceuticals Inc. company profile
View the public company page for Milestone Pharmaceuticals Inc. on 6ix.
Milestone Pharmaceuticals Inc. news
Read company news and market updates connected to Milestone Pharmaceuticals Inc..
Milestone Pharmaceuticals Inc. investor events
Find investor webinars, events, and replay context for Milestone Pharmaceuticals Inc..